SK7362002A3 - Solid pharmaceutical preparation - Google Patents

Solid pharmaceutical preparation Download PDF

Info

Publication number
SK7362002A3
SK7362002A3 SK736-2002A SK7362002A SK7362002A3 SK 7362002 A3 SK7362002 A3 SK 7362002A3 SK 7362002 A SK7362002 A SK 7362002A SK 7362002 A3 SK7362002 A3 SK 7362002A3
Authority
SK
Slovakia
Prior art keywords
compound
granules
crystal
drug substance
mixture
Prior art date
Application number
SK736-2002A
Other languages
English (en)
Slovak (sk)
Inventor
Motokazu Iwata
Terauki Kuriyama
Megumi Fujita
Keiichi Fujiwara
Shiro Kato
Hiroshi Harada
Akihito Fujii
Osamu Odai
Hitoshi Kawashima
Original Assignee
Dianippon Pharmaceutical Co Lt
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US09/661,577 external-priority patent/US6458824B1/en
Application filed by Dianippon Pharmaceutical Co Lt filed Critical Dianippon Pharmaceutical Co Lt
Publication of SK7362002A3 publication Critical patent/SK7362002A3/sk

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D209/00Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04Indoles; Hydrogenated indoles
    • C07D209/10Indoles; Hydrogenated indoles with substituted hydrocarbon radicals attached to carbon atoms of the hetero ring
    • C07D209/14Radicals substituted by nitrogen atoms, not forming part of a nitro radical
    • C07D209/16Tryptamines
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/04Anorexiants; Antiobesity agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/08Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Diabetes (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Child & Adolescent Psychology (AREA)
  • Emergency Medicine (AREA)
  • Endocrinology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Indole Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
SK736-2002A 1999-11-30 2000-11-24 Solid pharmaceutical preparation SK7362002A3 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP33954799 1999-11-30
US09/661,577 US6458824B1 (en) 1999-11-30 2000-09-14 Solid preparation
PCT/JP2000/008283 WO2001040182A2 (en) 1999-11-30 2000-11-24 Solid pharmaceutical preparation

Publications (1)

Publication Number Publication Date
SK7362002A3 true SK7362002A3 (en) 2003-02-04

Family

ID=26576443

Family Applications (1)

Application Number Title Priority Date Filing Date
SK736-2002A SK7362002A3 (en) 1999-11-30 2000-11-24 Solid pharmaceutical preparation

Country Status (14)

Country Link
EP (1) EP1235801A2 (no)
JP (1) JP2003515587A (no)
CN (1) CN1433403A (no)
AU (1) AU1550501A (no)
CA (1) CA2391646A1 (no)
CZ (1) CZ20021833A3 (no)
HU (1) HUP0203865A3 (no)
IL (1) IL149635A0 (no)
MX (1) MXPA02005326A (no)
NO (1) NO20022541L (no)
NZ (1) NZ519086A (no)
PL (1) PL356468A1 (no)
SK (1) SK7362002A3 (no)
WO (1) WO2001040182A2 (no)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20050010512A (ko) * 2002-06-12 2005-01-27 스미또모 세이야꾸 가부시키가이샤 인돌, 인다졸 및 벤즈아졸류
JP3759949B2 (ja) * 2002-12-17 2006-03-29 湧永製薬株式会社 遮光剤及び皮膜組成物
DK3023095T3 (en) * 2004-01-20 2018-08-20 Novartis Ag Directly pressed wording and approach

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SK281865B6 (sk) * 1994-11-29 2001-08-06 Dainippon Pharmaceutical Co., Ltd. Indolový derivát a jeho optický izomér, spôsob jeho prípravy a farmaceutický prostriedok
JPH11255743A (ja) * 1998-03-06 1999-09-21 Dainippon Pharmaceut Co Ltd 光学活性のインドール誘導体の製造方法及びその製造中間体

Also Published As

Publication number Publication date
PL356468A1 (en) 2004-06-28
AU1550501A (en) 2001-06-12
WO2001040182A3 (en) 2002-06-27
CZ20021833A3 (cs) 2003-02-12
IL149635A0 (en) 2002-11-10
EP1235801A2 (en) 2002-09-04
HUP0203865A2 (hu) 2003-03-28
WO2001040182A2 (en) 2001-06-07
NO20022541D0 (no) 2002-05-29
MXPA02005326A (es) 2003-02-12
CA2391646A1 (en) 2001-06-07
HUP0203865A3 (en) 2004-05-28
JP2003515587A (ja) 2003-05-07
NO20022541L (no) 2002-07-29
CN1433403A (zh) 2003-07-30
NZ519086A (en) 2003-11-28

Similar Documents

Publication Publication Date Title
CA2319308C (en) Pharmaceutical agents
US11708318B2 (en) Polymorphic forms of RAD1901-2HCL
US11643385B2 (en) Polymorphic forms of RAD1901-2HCl
US6458824B1 (en) Solid preparation
EA003551B1 (ru) Моногидрат гидробромида элетриптана в качестве селективного агониста 5-нтрецептора
SK7362002A3 (en) Solid pharmaceutical preparation
EP3653601A1 (en) Fenlean (flz) crystal b form, preparation method, and composition and use thereof
RU2125054C1 (ru) Кристаллические моногидраты гидрохлоридов эндо-2,3-дигидро-n-[8-метил-8- азабицикло(3,2,1)-окт-3-ил]-2-оксо-1h-бензимидазол-1-карбоксамида и эндо-3-этил-2,3- дигидро-n-[8-метил-8-азабицикло (3,2,1)-окт-3-ил]-2-оксо-1h-бензимидазол-1- карбоксамида, способ их получения и фармацевтическая композиция
AU3095600A (en) New pharmaceutical formulation
CN102666528A (zh) 晶体cdc7 抑制剂盐
RU2802964C2 (ru) Твердые формы 2-(5-(4-(2-морфолиноэтокси)фенил)пиридин-2-ил)-n-бензилацетамида
KR100256148B1 (ko) 결정 형태의 엔도-2,3-디하이드로-n-(8-메틸-8-아자비사이클로(3.2.1)옥트-3-일)-2-옥트-1h-벤즈이미다졸-1-카복스아미드 하이드로클로라이드 1수화물 및 엔도-3-에틸-2,3-디하이드로-n-(8-메틸-8-아자비시클로(3.2.1)옥트-3-일)-2옥소-1h-벤즈이미다졸-1-카복스아미드 하이드로클로라이드 1수화물
FI106021B (fi) Menetelmä N-[4-[5-(syklopentyylioksikarbonyyli)amino-1-metyyli-indol-3-yyli-metyyli]-3-metoksibentsoyyli]-2-metyylibentseenisulfonamidin fysikaalisen muodon valmistamiseksi

Legal Events

Date Code Title Description
FC9A Refused patent application